YU29202A - Alkilamino supstituisani biciklični azot heterocikli kao inhibitori p38 protein kinaze - Google Patents
Alkilamino supstituisani biciklični azot heterocikli kao inhibitori p38 protein kinazeInfo
- Publication number
- YU29202A YU29202A YU29202A YUP29202A YU29202A YU 29202 A YU29202 A YU 29202A YU 29202 A YU29202 A YU 29202A YU P29202 A YUP29202 A YU P29202A YU 29202 A YU29202 A YU 29202A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- inhibitors
- protein kinase
- substituted bicyclic
- nitrogen heterocycles
- alkylamino substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Opisani su alkilamino-supstituisani dihidropirimido-[4,5-d]pirimidinon derivati formule (I) u kojoj R1-R3 su kao što je opisano u prijavi koji su korisni kao inhibitori p38, zajedno sa postupcima za njihovu proizvodnju i farmaceutske smeše koje sadrže te derivate.[Alkylamino-substituted dihydropyrimido [4,5-d]pyrimidinone derivatives of formula (I) are provided wherein R1-R3 are as defined in the application which are useful as inhibitors of p38, along with a process for their manufacture and pharmaceutical preparations containing them.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16080499P | 1999-10-21 | 1999-10-21 | |
US21371800P | 2000-06-22 | 2000-06-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
YU29202A true YU29202A (sh) | 2004-12-31 |
Family
ID=26857242
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU29202A YU29202A (sh) | 1999-10-21 | 2000-10-13 | Alkilamino supstituisani biciklični azot heterocikli kao inhibitori p38 protein kinaze |
Country Status (25)
Country | Link |
---|---|
US (1) | US6642241B1 (sh) |
EP (1) | EP1226144B1 (sh) |
KR (1) | KR100537241B1 (sh) |
CN (1) | CN1156477C (sh) |
AR (1) | AR026187A1 (sh) |
AT (1) | ATE349447T1 (sh) |
AU (1) | AU776695B2 (sh) |
BR (1) | BR0014973A (sh) |
CA (1) | CA2388140C (sh) |
CO (1) | CO5251408A1 (sh) |
CZ (1) | CZ20021743A3 (sh) |
DE (1) | DE60032623T2 (sh) |
ES (1) | ES2277858T3 (sh) |
HK (1) | HK1051040A1 (sh) |
HR (1) | HRP20020327A2 (sh) |
HU (1) | HUP0203477A3 (sh) |
IL (1) | IL149230A0 (sh) |
MA (1) | MA26836A1 (sh) |
MX (1) | MXPA02003841A (sh) |
NO (1) | NO20021783L (sh) |
PE (1) | PE20010760A1 (sh) |
PL (1) | PL357494A1 (sh) |
TR (1) | TR200201058T2 (sh) |
WO (1) | WO2001029041A1 (sh) |
YU (1) | YU29202A (sh) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040044012A1 (en) * | 1998-05-26 | 2004-03-04 | Dobrusin Ellen Myra | Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
ES2310039T3 (es) | 1998-05-26 | 2008-12-16 | Warner-Lambert Company Llc | Pirimidinas biciclicas y 3,4-dihidropirimidinas biciclicas como inhibidores de la proliferacion celular. |
CN1646131A (zh) * | 2002-04-19 | 2005-07-27 | 史密丝克莱恩比彻姆公司 | 新化合物 |
WO2004004725A2 (en) | 2002-07-09 | 2004-01-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
US7196090B2 (en) | 2002-07-25 | 2007-03-27 | Warner-Lambert Company | Kinase inhibitors |
KR100793688B1 (ko) * | 2002-08-06 | 2008-01-10 | 에프. 호프만-라 로슈 아게 | P-38 미토겐 활성 단백질 키나제 억제제로서6-알콕시-피리도-피리미딘 |
ATE374201T1 (de) * | 2002-08-06 | 2007-10-15 | Hoffmann La Roche | 6-alkoxypyridopyrimidine als inhibitoren der p-38-map-kinase |
US7084270B2 (en) * | 2002-08-14 | 2006-08-01 | Hoffman-La Roche Inc. | Pyrimido compounds having antiproliferative activity |
US7129351B2 (en) | 2002-11-04 | 2006-10-31 | Hoffmann-La Roche Inc. | Pyrimido compounds having antiproliferative activity |
TW200413381A (en) | 2002-11-04 | 2004-08-01 | Hoffmann La Roche | Novel amino-substituted dihydropyrimido [4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents |
WO2004089955A1 (en) * | 2003-04-10 | 2004-10-21 | F.Hoffmann-La Roche Ag | Pyrimido compounds |
JP4659736B2 (ja) * | 2004-04-27 | 2011-03-30 | 武田薬品工業株式会社 | スクリーニング方法 |
US20060035893A1 (en) | 2004-08-07 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
JP2008509964A (ja) | 2004-08-31 | 2008-04-03 | エフ.ホフマン−ラ ロシュ アーゲー | 7−アミノ−3−フェニル−ジヒドロピリミド[4,5−d]ピリミジノンのアミド誘導体、これらの製造、及びプロテインキナーゼ阻害剤としての使用 |
BRPI0514738A (pt) | 2004-08-31 | 2008-06-24 | Hoffmann La Roche | derivados de amida de 3-fenil-diidropirimido[4,5-d]pirimidinonas, sua fabricação e aplicação como agentes farmacêuticos |
PE20060777A1 (es) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
AU2007211684A1 (en) | 2006-01-31 | 2007-08-09 | F. Hoffmann-La Roche Ag | 7H-pyrido[3,4-d]pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors |
EP1992344A1 (en) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation |
EP2108641A1 (en) * | 2008-04-11 | 2009-10-14 | Laboratorios Almirall, S.A. | New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
WO2012088266A2 (en) | 2010-12-22 | 2012-06-28 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3 |
CN107383009B (zh) | 2012-06-13 | 2020-06-09 | 因塞特控股公司 | 作为fgfr抑制剂的取代的三环化合物 |
WO2014026125A1 (en) | 2012-08-10 | 2014-02-13 | Incyte Corporation | Pyrazine derivatives as fgfr inhibitors |
US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
PE20151776A1 (es) | 2013-03-15 | 2015-12-11 | Celgene Avilomics Res Inc | Compuestos de heteroarilo y sus usos |
KR102350704B1 (ko) | 2013-03-15 | 2022-01-13 | 셀젠 카르 엘엘씨 | 헤테로아릴 화합물 및 이의 용도 |
TWI647220B (zh) | 2013-03-15 | 2019-01-11 | 美商西建卡爾有限責任公司 | 雜芳基化合物及其用途 |
SG11201508328PA (en) | 2013-04-19 | 2015-11-27 | Incyte Corp | Bicyclic heterocycles as fgfr inhibitors |
US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
WO2016134294A1 (en) | 2015-02-20 | 2016-08-25 | Incyte Corporation | Bicyclic heterocycles as fgfr4 inhibitors |
CN107438607B (zh) | 2015-02-20 | 2021-02-05 | 因赛特公司 | 作为fgfr抑制剂的双环杂环 |
MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
WO2019071144A1 (en) | 2017-10-05 | 2019-04-11 | Fulcrum Therapeutics, Inc. | USE OF P38 INHIBITORS TO REDUCE DUX4 EXPRESSION |
US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
CA3099116A1 (en) | 2018-05-04 | 2019-11-07 | Incyte Corporation | Salts of an fgfr inhibitor |
AU2019262195B2 (en) | 2018-05-04 | 2024-09-12 | Incyte Corporation | Solid forms of an FGFR inhibitor and processes for preparing the same |
US11628162B2 (en) | 2019-03-08 | 2023-04-18 | Incyte Corporation | Methods of treating cancer with an FGFR inhibitor |
WO2021007269A1 (en) | 2019-07-09 | 2021-01-14 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
JP2022552324A (ja) | 2019-10-14 | 2022-12-15 | インサイト・コーポレイション | Fgfr阻害剤としての二環式複素環 |
US11566028B2 (en) | 2019-10-16 | 2023-01-31 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
GB201915828D0 (en) * | 2019-10-31 | 2019-12-18 | Cancer Research Tech Ltd | Compounds, compositions and therapeutic uses thereof |
CA3163875A1 (en) | 2019-12-04 | 2021-06-10 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
KR20220131900A (ko) | 2019-12-04 | 2022-09-29 | 인사이트 코포레이션 | Fgfr 억제제의 유도체 |
WO2021146424A1 (en) | 2020-01-15 | 2021-07-22 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
US12065494B2 (en) | 2021-04-12 | 2024-08-20 | Incyte Corporation | Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent |
JP2024522189A (ja) | 2021-06-09 | 2024-06-11 | インサイト・コーポレイション | Fgfr阻害剤としての三環式ヘテロ環 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8814352D0 (en) | 1988-06-16 | 1988-07-20 | Smith Kline French Lab | Chemical compounds |
IL117923A (en) | 1995-05-03 | 2000-06-01 | Warner Lambert Co | Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds |
US6147080A (en) * | 1996-12-18 | 2000-11-14 | Vertex Pharmaceuticals Incorporated | Inhibitors of p38 |
KR100378937B1 (ko) * | 1997-10-20 | 2003-05-09 | 에프. 호프만-라 로슈 아게 | 바이사이클릭 키나아제 억제제 |
ES2310039T3 (es) * | 1998-05-26 | 2008-12-16 | Warner-Lambert Company Llc | Pirimidinas biciclicas y 3,4-dihidropirimidinas biciclicas como inhibidores de la proliferacion celular. |
ID28276A (id) | 1998-10-23 | 2001-05-10 | Hoffmann La Roche | Heterolingkar nitrogen bisiklik |
-
2000
- 2000-10-13 CZ CZ20021743A patent/CZ20021743A3/cs unknown
- 2000-10-13 BR BR0014973-0A patent/BR0014973A/pt not_active IP Right Cessation
- 2000-10-13 ES ES00972755T patent/ES2277858T3/es not_active Expired - Lifetime
- 2000-10-13 AU AU11375/01A patent/AU776695B2/en not_active Ceased
- 2000-10-13 HU HU0203477A patent/HUP0203477A3/hu unknown
- 2000-10-13 YU YU29202A patent/YU29202A/sh unknown
- 2000-10-13 TR TR2002/01058T patent/TR200201058T2/xx unknown
- 2000-10-13 MX MXPA02003841A patent/MXPA02003841A/es active IP Right Grant
- 2000-10-13 IL IL14923000A patent/IL149230A0/xx unknown
- 2000-10-13 CN CNB00814544XA patent/CN1156477C/zh not_active Expired - Fee Related
- 2000-10-13 DE DE60032623T patent/DE60032623T2/de not_active Expired - Fee Related
- 2000-10-13 KR KR10-2002-7005056A patent/KR100537241B1/ko not_active IP Right Cessation
- 2000-10-13 AT AT00972755T patent/ATE349447T1/de not_active IP Right Cessation
- 2000-10-13 WO PCT/EP2000/010077 patent/WO2001029041A1/en not_active Application Discontinuation
- 2000-10-13 PL PL00357494A patent/PL357494A1/xx not_active Application Discontinuation
- 2000-10-13 EP EP00972755A patent/EP1226144B1/en not_active Expired - Lifetime
- 2000-10-13 CA CA002388140A patent/CA2388140C/en not_active Expired - Fee Related
- 2000-10-17 PE PE2000001106A patent/PE20010760A1/es not_active Application Discontinuation
- 2000-10-19 CO CO00079670A patent/CO5251408A1/es not_active Application Discontinuation
- 2000-10-20 US US09/693,364 patent/US6642241B1/en not_active Expired - Fee Related
- 2000-10-20 AR ARP000105524A patent/AR026187A1/es not_active Application Discontinuation
-
2002
- 2002-04-12 HR HR20020327A patent/HRP20020327A2/hr not_active Application Discontinuation
- 2002-04-16 NO NO20021783A patent/NO20021783L/no not_active Application Discontinuation
- 2002-04-19 MA MA26611A patent/MA26836A1/fr unknown
-
2003
- 2003-05-06 HK HK03103209A patent/HK1051040A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO20021783D0 (no) | 2002-04-16 |
AR026187A1 (es) | 2003-01-29 |
EP1226144A1 (en) | 2002-07-31 |
CO5251408A1 (es) | 2003-02-28 |
HUP0203477A3 (en) | 2004-12-28 |
KR20020039375A (ko) | 2002-05-25 |
EP1226144B1 (en) | 2006-12-27 |
DE60032623T2 (de) | 2007-10-11 |
CN1382142A (zh) | 2002-11-27 |
AU776695B2 (en) | 2004-09-16 |
ATE349447T1 (de) | 2007-01-15 |
HK1051040A1 (en) | 2003-07-18 |
US6642241B1 (en) | 2003-11-04 |
MA26836A1 (fr) | 2004-12-20 |
ES2277858T3 (es) | 2007-08-01 |
JP4028236B2 (ja) | 2007-12-26 |
HRP20020327A2 (en) | 2004-02-29 |
PE20010760A1 (es) | 2001-07-21 |
MXPA02003841A (es) | 2002-09-30 |
JP2003512377A (ja) | 2003-04-02 |
CZ20021743A3 (cs) | 2002-08-14 |
CA2388140C (en) | 2008-09-02 |
DE60032623D1 (de) | 2007-02-08 |
KR100537241B1 (ko) | 2005-12-19 |
PL357494A1 (en) | 2004-07-26 |
CA2388140A1 (en) | 2001-04-26 |
IL149230A0 (en) | 2002-11-10 |
BR0014973A (pt) | 2002-07-16 |
NO20021783L (no) | 2002-04-16 |
WO2001029041A1 (en) | 2001-04-26 |
AU1137501A (en) | 2001-04-30 |
CN1156477C (zh) | 2004-07-07 |
HUP0203477A2 (hu) | 2003-01-28 |
TR200201058T2 (tr) | 2002-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU29202A (sh) | Alkilamino supstituisani biciklični azot heterocikli kao inhibitori p38 protein kinaze | |
MX9800215A (es) | Pirrolopirimidas y procesos para su preparacion. | |
AU687909B2 (en) | Protein kinase C inhibitors | |
AP9701146A0 (en) | Fused bicyclic pyrimidine derivatives. | |
GEP20063784B (en) | Optical Resolution of (1-Benzyl-4- Methylpiperidin-3-Yl) -Methylamine Enantiomers and Use Thereof for Preparation of Pyrrolo 2,3-Pyrimidine Derivatives as Protein Kinases Inhibitors | |
IL117923A0 (en) | Pyrido [2,3-d] pyrimidine derivatives and pharmaceutical compositions containing them | |
AP9901435A0 (en) | Bicycle heteroaromatic compounds as protein tyrosine kinase inhibitors. | |
DE69804743D1 (de) | Pyrazolo[4,3-d]pyrimidin-Derivate und diese enthaltende pharmazeutische Zubereitungen | |
HUP0203564A3 (en) | Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinease, process for their preparation and pharmaceutical compositions containing them | |
HUT70505A (en) | Pyrrolo[2,3-d]pyrimidine derivatives, pharmaceutical compositions containing them and process for preparing them | |
MX9702307A (es) | Pirrolo (2,3-d)pirimidinas y su uso. | |
SE9702001D0 (sv) | Novel compounds | |
AP1911A (en) | Pyrrolo[2,3-d]pyrimidine compounds. | |
MX9707431A (es) | Inhibidores de la proteina cinasa c. | |
IL115970A0 (en) | 6-aryl pyrido [2 3-d] pyrimidines and naphthyridines pharmaceutical compositions containing them and their use | |
UA34423C2 (uk) | Спосіб одержання заміщених в п'ятому положенні піроло[2,3-d]піримідинів | |
NO993027L (no) | Pyrrolo[3,4-D]pyrimidinonderivater og deres anvendelse som legemidler | |
AU8117798A (en) | Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors | |
MY103766A (en) | Pyrrolo[1,2-a]imidazole and imidazo[1,2-a] pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors | |
ZA200202540B (en) | Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase. |